FDA-approved AI diagnostic tools already operate autonomously for specific conditions. IDx-DR reads retinal scans without physician review, and the FDA's 2018 authorization was grounded in clinical evidence that autonomous AI was safer than the available alternative — which was no screening at all. Extending this model to other well-validated conditions follows the same logic already applied.
